1. Home
  2. KMT vs ANIP Comparison

KMT vs ANIP Comparison

Compare KMT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$29.54

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$72.64

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
ANIP
Founded
1938
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
1.9B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
KMT
ANIP
Price
$29.54
$72.64
Analyst Decision
Sell
Buy
Analyst Count
8
9
Target Price
$31.43
★ $105.78
AVG Volume (30 Days)
★ 1.2M
295.9K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 2.70%
N/A
EPS Growth
268.33
★ 419.23
EPS
★ 4.42
2.32
Revenue
★ $2,356,698,000.00
$206,547,000.00
Revenue This Year
$43.37
$24.85
Revenue Next Year
$2.98
$10.76
P/E Ratio
★ $6.67
$31.75
Revenue Growth
★ 19.82
2.47
52 Week Low
$21.70
$69.58
52 Week High
$43.81
$96.57

Technical Indicators

Market Signals
Indicator
KMT
ANIP
Relative Strength Index (RSI) 38.50 49.08
Support Level $28.97 $69.88
Resistance Level $31.15 $83.03
Average True Range (ATR) 0.94 1.92
MACD -0.25 0.18
Stochastic Oscillator 14.35 62.27

Price Performance

Historical Comparison
KMT
ANIP

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: